Clinical Trials
Catherine Curtin, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting
Dyani Gaudilliere, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting
David Kahn, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting
Gordon Lee, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting
H. Peter Lorenz, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting
Arash Momeni, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting
Dung Nguyen, MD
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]FDG
- device: PET/MRI
Eligibility
Inclusion Criteria:
- Age 18 years or older.
- Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, and migraine.
- Provides informed consent
- On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
- MRI-incompatible
- Diabetes
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sunyoung Park, BA
Not Recruiting